Real-World Experience and Clinical Utility of a Non-Invasive Gene Expression Rule-Out Test for Melanoma and Additional Validation Against High Risk Driver Mutations in BRAF, NRAS and the TERT Promoter. J of Skin 2018, 2, S69. https://doi.org/10.25251/skin.2.supp.69.